Cord Blood Stem Cells Information

Hematopoietic Stem Cells News

Yield For Pharmacologically Stimulated Stem Cell Mobilization Influenced By Time Of DayThursday, October 9, 2008 @ 8:17AMA new study uncovers a previously unrecognized, species-specific impact of circadian rhythms on the production of mobilized stem cells. The research, published by Cell Press in the October 9th issue of the journal Cell Stem Cell, suggests that when it comes to collecting human stem cells for clinical transplantation, picking the right time of day to harvest cells may result in a greater yield.

Time of day influences yield for pharmacologically stimulated stem cell mobilizationWednesday, October 8, 2008 @ 11:19AMA new study uncovers a previously unrecognized, species-specific impact of circadian rhythms on the production of mobilized stem cells. The research, published by Cell Press in the Oct. 9 issue of the journal Cell Stem Cell, suggests that when it comes to collecting human stem cells for clinical transplantation, picking the right time of day to harvest cells may result in a greater yield.

LifeSource Cryobank Only Company in U.S. to Extract and Store Stem Cells Directly from Bone MarrowTuesday, October 7, 2008 @ 8:45AM COVINGTON, La.----Using an advanced medical technique, doctors at LifeSource Cryobank, LLC can extract, purify, expand and store a type of stem cells directly from bone marrow. Because these stem cells give rise to or participate in the formation of bone, muscle, cartilage, blood vessels and other tissues and organs, they are far superior to hematopoietic stem cells that can only regenerate new ...

DOR BioPharma Forms orBec® European Medical Advisory BoardFriday, September 19, 2008 @ 6:03AMDOR BioPharma, Inc. announced recently the formation of a European Medical Advisory Board (MAB) to provide medical/clinical strategic guidance to the Company as it relates to the ongoing development of orBec for the treatment of gastrointestinal Graft-versus-Host disease (GI GVHD).

International Science Linkages announcedThursday, September 18, 2008 @ 12:21AMSydney University has been successful in securing a significant proportion of the federal funding for new international research projects announced this week.

Subscribe to the Daily Headlines E-mailWednesday, September 3, 2008 @ 4:41AMNearly 15 years ago, scientists completed one of the largest international projects in research history, tremendous in its scope and importance. They determined the sequence of the nearly 30,000 genes in the human genome.

ImmuneRegen(R) BioSciences Confirms Homspera(R) Advances Wound Healing In Topical ApplicationMonday, August 18, 2008 @ 7:15AMImmuneRegen® BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), announced that in a controlled study performed on Yorkshire pigs, its wound-healing drug candidate, Homspera®, has accelerated the healing process of deep, dermal excisions. ImmuneRegen performed the in vivo study with Bio-Quant, Inc.

ImmuneRegen(R) BioSciences Confirms Homspera(R) Advances Wound Healing in Topical ApplicationWednesday, August 13, 2008 @ 5:53AMImmuneRegen(R) BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBS), today announced that in a controlled study performed on Yorkshire pigs, its wound-healing drug candidate, Homspera(R), has accelerated the healing process of deep, dermal excisions. ImmuneRegen performed the in vivo study with Bio-Quant, Inc., a biotechnology development company that also ...

ImmuneRegen(R) BioSciences Confirms Homspera(R) Advances Wound Healing in Topical ApplicationWednesday, August 13, 2008 @ 5:30AM SCOTTSDALE, Ariz.----ImmuneRegen® BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. , today announced that in a controlled study performed on Yorkshire pigs, its wound-healing drug candidate, Homspera®, has accelerated the healing process of deep, dermal excisions.